Our study is the first report that indicates Sirt3 might be the downstream target and a novel aspect explaining the beneficial and clinically relevant PPAR-γ effectively in improving neurodegenerative and inflammatory processes during stroke. Here, SIRT3 is linked to stroke disorder.